Heavy Menstrual Bleeding in Von Willebrand Disease — Treatment for Women Wishing to Conceive

Women with Von Willebrand disease who experience heavy menstrual bleeding and are planning pregnancy represent a distinct clinical subgroup. Therapy selection in this setting must account for both bleeding management and reproductive considerations.

Clinical scenario: Female patient with Von Willebrand disease presenting with heavy menstrual bleeding, with the additional factor that she wishes to conceive. This combination constrains the therapeutic options and guides the preferred approach.

Treatment approach

In this specific setting, a preferred pharmacological intervention has been identified over alternative agents — guided by the need to manage bleeding while preserving the option of conception. The complete recommendation, rationale, and clinical details are available in the full protocol.

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.1182/bloodadvances.2020003264.

The panel suggests using tranexamic acid over desmopressin to treat women with VWD and heavy menstrual bleeding who wish to conceive (conditional recommendation based on very low certainty in the evidence).

View source ↗